Recent medical breakthroughs in cell and gene therapy have signaled a coming revolution in patient care for previously untreatable disease. We at Mustang Bio are translating these breakthroughs into next-generation therapies for hematologic cancers, glioblastoma and rare genetic diseases.
Our world-class team of cell and gene therapy experts is developing next generation medicines in areas of high patient need
Our unique model of in-licensing potential first in class therapeutic candidates from top institutions minimizes development risk and maximizes opportunity for success
The energy and passion of our people drives our mission to bring hope to patients worldwide
We expect to advance 2-3 new therapeutic candidates into the clinic annually, and have developed the manufacturing expertise required to develop and commericalize these therapies on a broad scale.
To learn more about our team, visit the Leadership page.
To learn more about our approach, visit the Our Approach page.